{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:54:24Z","timestamp":1791021264405,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007406","name":"Fundaci\u00f3n BBVA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["0011\u20131411-2023"],"award-info":[{"award-number":["0011\u20131411-2023"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020082","name":"Gobierno de Navarra Direccion General de Industria Energia y Proyectos Estrategicos S3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2020-112892RB-100"],"award-info":[{"award-number":["PID2020-112892RB-100"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2020-113174-RA-100"],"award-info":[{"award-number":["PID2020-113174-RA-100"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2014-52361-R"],"award-info":[{"award-number":["SAF2014-52361-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01128"],"award-info":[{"award-number":["PI19\/01128"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00002"],"award-info":[{"award-number":["PI20\/00002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00147"],"award-info":[{"award-number":["PI22\/00147"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RyC 2019-026406-I"],"award-info":[{"award-number":["RyC 2019-026406-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["765394"],"award-info":[{"award-number":["765394"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.omtn.2023.07.020","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T02:30:52Z","timestamp":1689733852000},"page":"599-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Intratumoral injection of IL-12-encoding mRNA targeted to CSF1R and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure"],"prefix":"10.1016","volume":"33","author":[{"given":"Claudia Augusta","family":"Di Trani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Cirella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Arrizabalaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Fernandez-Sendin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Salvador","family":"Russo-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Gomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Ardaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Teijeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elixabet","family":"Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Gonz\u00e1lez-Gomariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Otano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Palencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Segu\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander M.J.","family":"van Duijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"van Elsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-1865","authenticated-orcid":false,"given":"Pedro","family":"Berraondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.07.020_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omtn.2023.07.020_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-immunol-042718-041407","article-title":"Emerging Cellular Therapies for Cancer","volume":"12","author":"Guedan","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtn.2023.07.020_bib3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtn.2023.07.020_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/d41573-022-00030-4","article-title":"Challenges and opportunities in the PD1\/PDL1 inhibitor clinical trial landscape","volume":"21","author":"Upadhaya","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2023.07.020_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.07.020_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s43018-022-00401-1","article-title":"Charting roadmaps towards novel and safe synergistic immunotherapy combinations","volume":"3","author":"Sanmamed","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omtn.2023.07.020_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omtn.2023.07.020_bib8","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.4049\/jimmunol.172.11.6775","article-title":"Early target genes of IL-12 and STAT4 signaling in th cells","volume":"172","author":"Lund","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2023.07.020_bib9","doi-asserted-by":"crossref","first-page":"12281","DOI":"10.1073\/pnas.182618999","article-title":"STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation","volume":"99","author":"Morinobu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.07.020_bib10","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1182\/blood.V87.9.3877.bloodjournal8793877","article-title":"Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10","volume":"87","author":"Sgadari","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2023.07.020_bib11","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1172\/JCI58814","article-title":"IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors","volume":"121","author":"Kerkar","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2023.07.020_bib12","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4049\/jimmunol.140.5.1660","article-title":"Regulation of HLA-DR gene by IFN-gamma. Transcriptional and post-transcriptional control","volume":"140","author":"Rosa","year":"1988","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2023.07.020_bib13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.177.6.1809","article-title":"Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T\u00a0cell adhesion to endothelial cells","volume":"177","author":"Taub","year":"1993","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtn.2023.07.020_bib14","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2023.07.020_bib15","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2023.07.020_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108189","article-title":"Novel strategies exploiting interleukin-12 in cancer immunotherapy","volume":"239","author":"Cirella","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2023.07.020_bib17","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1158\/1078-0432.CCR-20-0472","article-title":"Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment","volume":"26","author":"Hewitt","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2023.07.020_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2023.07.020_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc7804","article-title":"Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models","volume":"13","author":"Hotz","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2023.07.020_bib20","series-title":"Intratumoral Gene Transfer of mRNAs Encoding Interleukin-12 in Combination with Decoy-Resistant Interleukin-18 Improves Local and Systemic Antitumor Immunity","author":"Cirella","year":"2022"},{"key":"10.1016\/j.omtn.2023.07.020_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/17460441.2021.1978972","article-title":"Advances in mRNA-based drug discovery in cancer immunotherapy","volume":"17","author":"Di Trani","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.omtn.2023.07.020_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omtn.2023.07.020_bib23","doi-asserted-by":"crossref","first-page":"xii33","DOI":"10.1093\/annonc\/mdx683","article-title":"Intratumoral immunotherapy: using the tumor as the remedy","volume":"28","author":"Marabelle","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omtn.2023.07.020_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/bs.ircmb.2022.05.002","article-title":"Overcoming the limitations of cytokines to improve cancer therapy","volume":"369","author":"Di Trani","year":"2022","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.omtn.2023.07.020_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2022.40.6_suppl.127","article-title":"The immunocytokine M9241 in the treatment of prostate cancer (PCa): Clinical and immune data from a phase 1 study","volume":"40","author":"Meininger","year":"2022","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omtn.2023.07.020_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nbt0197-35","article-title":"Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in\u00a0vivo","volume":"15","author":"Lieschke","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.07.020_bib27","doi-asserted-by":"crossref","first-page":"10100","DOI":"10.18632\/oncotarget.2463","article-title":"Intratumoral administration of mRNA encoding a fusokine consisting of IFN-\u03b2 and the ectodomain of the TGF-\u03b2 receptor II potentiates antitumor immunity","volume":"5","author":"Van der Jeught","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2023.07.020_bib28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.gt.3302964","article-title":"Spontaneous cellular uptake of exogenous messenger RNA in\u00a0vivo is nucleic acid-specific, saturable and ion dependent","volume":"14","author":"Probst","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2023.07.020_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/2326-6066.CIR-15-0163","article-title":"Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells","volume":"4","author":"Van Lint","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omtn.2023.07.020_bib30","first-page":"4696","article-title":"The role of IFN-gamma in rejection of established tumors by IL-12 : source of production and target","volume":"62","author":"Segal","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2023.07.020_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002371-199502000-00001","article-title":"Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12","volume":"17","author":"Brunda","year":"1995","journal-title":"J.\u00a0Immunother. Emphasis Tumor Immunol."},{"key":"10.1016\/j.omtn.2023.07.020_bib32","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V96.4.1465","article-title":"Coadministration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: critical role of natural killer cell interferon-gamma production and STAT-mediated signal transduction","volume":"96","author":"Carson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2023.07.020_bib33","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1158\/1078-0432.CCR-20-3250","article-title":"Interleukin-12 Message in a Bottle","volume":"26","author":"Cirella","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2023.07.020_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omtn.2023.07.020_bib35","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1158\/0008-5472.CAN-06-1991","article-title":"Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression","volume":"67","author":"Kirma","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2023.07.020_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3311","article-title":"T cell-induced CSF1 promotes melanoma resistance to PD1 blockade","volume":"10","author":"Neubert","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2023.07.020_bib37","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","article-title":"CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models","volume":"74","author":"Zhu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2023.07.020_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omtn.2023.07.020_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2023.07.020_bib40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1158\/2326-6066.CIR-14-0216","article-title":"Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1\/PD-L1 Blockade","volume":"3","author":"Quetglas","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omtn.2023.07.020_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.omtn.2022.07.020","article-title":"Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer","volume":"29","author":"Silva-Pilipich","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.07.020_bib42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2023.07.020_bib43","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.07.020_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020460","article-title":"The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA","volume":"14","author":"Taina-Gonz\u00e1lez","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2023.07.020_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2023.07.020_bib46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ccell.2019.10.006","article-title":"Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8","volume":"36","author":"Etxeberria","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2023.07.020_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2147317","article-title":"Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8","volume":"12","author":"Di Trani","year":"2023","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omtn.2023.07.020_bib48","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","article-title":"Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells","volume":"108","author":"Holtkamp","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2023.07.020_bib49","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.07.020_bib50","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2023.07.020_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41592-019-0654-x","article-title":"Orchestrating single-cell analysis with Bioconductor","volume":"17","author":"Amezquita","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2023.07.020_bib52","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123001932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123001932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:36:56Z","timestamp":1761874616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253123001932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":52,"alternative-id":["S2162253123001932"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.07.020","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratumoral injection of IL-12-encoding mRNA targeted to CSF1R and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}